Heart Test Laboratories, Inc. (HeartSciences), a medical technology company, has announced a securities offering of up to 1,882,353 shares of its common stock. The offering is being managed by Maxim Group LLC as the exclusive placement agent. The company has also agreed to issue placement agent warrants for the purchase of up to 75,294 shares of common stock, with the warrants exercisable at 110% of the public offering price. The offering is being conducted on a best-efforts basis, with no minimum amount of securities required to be sold for the offering to proceed. The actual public offering price will be determined through negotiations between HeartSciences, the placement agent, and investors. The offering is subject to various terms and conditions as outlined in...Show More

Heart Test Laboratories, Inc. (HeartSciences), a medical technology company, has announced a securities offering of up to 1,882,353 shares of its common stock. The offering is being managed by Maxim Group LLC as the exclusive placement agent. The company has also agreed to issue placement agent warrants for the purchase of up to 75,294 shares of common stock, with the warrants exercisable at 110% of the public offering price. The offering is being conducted on a best-efforts basis, with no minimum amount of securities required to be sold for the offering to proceed. The actual public offering price will be determined through negotiations between HeartSciences, the placement agent, and investors. The offering is subject to various terms and conditions as outlined in a placement agency agreement and securities purchase agreements with investors. HeartSciences intends to use the net proceeds from the offering for FDA clearance-related costs, commercial development of licensed AI cardiovascular algorithms, research and development, working capital, and other general corporate purposes. The offering includes certain lock-up agreements restricting the issuance and sale of additional securities by the company and its officers and directors for specified periods post-offering. The common stock is listed on the Nasdaq Capital Market under the symbol 'HSCS'.